A unique binding epitope for salvinorin A, a non-nitrogenous kappa opioid receptor agonist

Brian E. Kane, Marcelo J. Nieto, Christopher R. McCurdy, David M Ferguson

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

Salvinorin A is a potent kappa opioid receptor (KOP) agonist with unique structural and pharmacological properties. This non-nitrogenous ligand lacks nearly all the structural features commonly associated with opioid ligand binding and selectivity. This study explores the structural basis to salvinorin A binding and selectivity using a combination of chimeric and single-point mutant opioid receptors. The experiments were designed based on previous models of salvinorin A that locate the ligand within a pocket formed by transmembrane (TM) II, VI, and VII. More traditional sites of opioid recognition were also explored, including the highly conserved aspartate in TM III (D138) and the KOP selectivity site E297, to determine the role, if any, that these residues play in binding and selectivity. The results indicate that salvinorin A recognizes a cluster of residues in TM II and VII, including Q115, Y119, Y312, Y313, and Y320. Based on the position of these residues within the receptor, and prior study on salvinorin A, a model is proposed that aligns the ligand vertically, between TM II and VII. In this orientation, the ligand spans residues that are spaced one to two turns down the face of the helices within the receptor cavity. The ligand is also in close proximity to EL-2 which, based on chimeric data, is proposed to play an indirect role in salvinorin A binding and selectivity.

Original languageEnglish (US)
Pages (from-to)1966-1974
Number of pages9
JournalFEBS Journal
Volume273
Issue number9
DOIs
StatePublished - May 1 2006

Fingerprint

salvinorin A
kappa Opioid Receptor
Epitopes
Ligands
Opioid Analgesics
Opioid Receptors
Aspartic Acid

Keywords

  • Chimeric
  • Kappa opioid
  • Molecular biology
  • Mutagenesis
  • Salvinorin

Cite this

A unique binding epitope for salvinorin A, a non-nitrogenous kappa opioid receptor agonist. / Kane, Brian E.; Nieto, Marcelo J.; McCurdy, Christopher R.; Ferguson, David M.

In: FEBS Journal, Vol. 273, No. 9, 01.05.2006, p. 1966-1974.

Research output: Contribution to journalArticle

Kane, Brian E. ; Nieto, Marcelo J. ; McCurdy, Christopher R. ; Ferguson, David M. / A unique binding epitope for salvinorin A, a non-nitrogenous kappa opioid receptor agonist. In: FEBS Journal. 2006 ; Vol. 273, No. 9. pp. 1966-1974.
@article{c5e365dc17e4431dbb36a92cdd89f715,
title = "A unique binding epitope for salvinorin A, a non-nitrogenous kappa opioid receptor agonist",
abstract = "Salvinorin A is a potent kappa opioid receptor (KOP) agonist with unique structural and pharmacological properties. This non-nitrogenous ligand lacks nearly all the structural features commonly associated with opioid ligand binding and selectivity. This study explores the structural basis to salvinorin A binding and selectivity using a combination of chimeric and single-point mutant opioid receptors. The experiments were designed based on previous models of salvinorin A that locate the ligand within a pocket formed by transmembrane (TM) II, VI, and VII. More traditional sites of opioid recognition were also explored, including the highly conserved aspartate in TM III (D138) and the KOP selectivity site E297, to determine the role, if any, that these residues play in binding and selectivity. The results indicate that salvinorin A recognizes a cluster of residues in TM II and VII, including Q115, Y119, Y312, Y313, and Y320. Based on the position of these residues within the receptor, and prior study on salvinorin A, a model is proposed that aligns the ligand vertically, between TM II and VII. In this orientation, the ligand spans residues that are spaced one to two turns down the face of the helices within the receptor cavity. The ligand is also in close proximity to EL-2 which, based on chimeric data, is proposed to play an indirect role in salvinorin A binding and selectivity.",
keywords = "Chimeric, Kappa opioid, Molecular biology, Mutagenesis, Salvinorin",
author = "Kane, {Brian E.} and Nieto, {Marcelo J.} and McCurdy, {Christopher R.} and Ferguson, {David M}",
year = "2006",
month = "5",
day = "1",
doi = "10.1111/j.1742-4658.2006.05212.x",
language = "English (US)",
volume = "273",
pages = "1966--1974",
journal = "FEBS Journal",
issn = "1742-464X",
publisher = "Wiley-Blackwell",
number = "9",

}

TY - JOUR

T1 - A unique binding epitope for salvinorin A, a non-nitrogenous kappa opioid receptor agonist

AU - Kane, Brian E.

AU - Nieto, Marcelo J.

AU - McCurdy, Christopher R.

AU - Ferguson, David M

PY - 2006/5/1

Y1 - 2006/5/1

N2 - Salvinorin A is a potent kappa opioid receptor (KOP) agonist with unique structural and pharmacological properties. This non-nitrogenous ligand lacks nearly all the structural features commonly associated with opioid ligand binding and selectivity. This study explores the structural basis to salvinorin A binding and selectivity using a combination of chimeric and single-point mutant opioid receptors. The experiments were designed based on previous models of salvinorin A that locate the ligand within a pocket formed by transmembrane (TM) II, VI, and VII. More traditional sites of opioid recognition were also explored, including the highly conserved aspartate in TM III (D138) and the KOP selectivity site E297, to determine the role, if any, that these residues play in binding and selectivity. The results indicate that salvinorin A recognizes a cluster of residues in TM II and VII, including Q115, Y119, Y312, Y313, and Y320. Based on the position of these residues within the receptor, and prior study on salvinorin A, a model is proposed that aligns the ligand vertically, between TM II and VII. In this orientation, the ligand spans residues that are spaced one to two turns down the face of the helices within the receptor cavity. The ligand is also in close proximity to EL-2 which, based on chimeric data, is proposed to play an indirect role in salvinorin A binding and selectivity.

AB - Salvinorin A is a potent kappa opioid receptor (KOP) agonist with unique structural and pharmacological properties. This non-nitrogenous ligand lacks nearly all the structural features commonly associated with opioid ligand binding and selectivity. This study explores the structural basis to salvinorin A binding and selectivity using a combination of chimeric and single-point mutant opioid receptors. The experiments were designed based on previous models of salvinorin A that locate the ligand within a pocket formed by transmembrane (TM) II, VI, and VII. More traditional sites of opioid recognition were also explored, including the highly conserved aspartate in TM III (D138) and the KOP selectivity site E297, to determine the role, if any, that these residues play in binding and selectivity. The results indicate that salvinorin A recognizes a cluster of residues in TM II and VII, including Q115, Y119, Y312, Y313, and Y320. Based on the position of these residues within the receptor, and prior study on salvinorin A, a model is proposed that aligns the ligand vertically, between TM II and VII. In this orientation, the ligand spans residues that are spaced one to two turns down the face of the helices within the receptor cavity. The ligand is also in close proximity to EL-2 which, based on chimeric data, is proposed to play an indirect role in salvinorin A binding and selectivity.

KW - Chimeric

KW - Kappa opioid

KW - Molecular biology

KW - Mutagenesis

KW - Salvinorin

UR - http://www.scopus.com/inward/record.url?scp=33646271609&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33646271609&partnerID=8YFLogxK

U2 - 10.1111/j.1742-4658.2006.05212.x

DO - 10.1111/j.1742-4658.2006.05212.x

M3 - Article

C2 - 16640560

AN - SCOPUS:33646271609

VL - 273

SP - 1966

EP - 1974

JO - FEBS Journal

JF - FEBS Journal

SN - 1742-464X

IS - 9

ER -